Freed Focuses on Small Practices

This positioning gives Freed a real lane because it sells to doctors who can buy on their own, while Abridge increasingly sells into health systems through the EHR. In practice, Freed can win a solo doctor or a five doctor clinic with a simple $99 per month product that records the visit, writes the note, and lets the clinician paste it into the chart. Abridge is optimized for a different buyer, a hospital or large group that wants deep Epic and athenahealth workflow integration, compliance review, and billing support.

• Freed grew by going bottom up into practices with fewer than 10 doctors, a segment that represents 47% of U.S. clinicians. That matters because the user is often also the buyer, so adoption can happen without a long enterprise sale or an EHR partnership first.
  1 sacra 3 sacra
• Abridge has taken the opposite route. It partnered with Epic in August 2023 and athenahealth in February 2025, then expanded from about 8,000 to more than 60,000 clinicians across 100 plus health systems by May 2025. Its product is priced around $500 per clinician per month and is increasingly tied to integrated documentation and revenue workflows.
  2 sacra 4 athenahealth 5 beckershospitalreview
• The tradeoff is that standalone works best early, not forever. Once a clinic grows, wants orders and diagnoses written directly into the EHR, or has to route purchases through IT and compliance, the sale starts to look enterprise. That is where Abridge has an advantage and where Freed needs deeper integrations to keep expanding account size.
  1 sacra 3 sacra

The market is splitting into two durable motions. One is lightweight, self serve software for fragmented small practices. The other is deeply integrated infrastructure for health systems. Freed can keep compounding if it becomes the default tool for independent outpatient doctors, then adds just enough EHR depth and compliance tooling to move from single clinician adoption to group wide standardization.